Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Cardiff Oncology, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 110 | 2 | 117 | +9 |
| Shares | 27.2M | 3.72M | 24.6M | +1.07M (+4.6%) |
| Value | $76.6M | $10.5M | $39.7M | −$26.4M (−39.9%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Cardiff Oncology, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 2,855,966 | $4.63M | 0.00% |
| Vanguard Fiduciary Trust Co | 446,225 | $722.9K | 0.00% |
| Vanguard Portfolio Management LLC | 437,214 | $708.3K | 0.00% |
| Renaissance Technologies LLC | 101,253 | $164.0K | 0.00% |
| AQR Capital Management LLC | 66,156 | $107.2K | 0.00% |
| SEI Investments Co | 54,685 | $88.6K | 0.00% |
| Squarepoint Ops LLC | 26,356 | $42.7K | 0.00% |
| Vanguard Global Advisers, LLC | 25,271 | $40.9K | 0.00% |
| Brighton Jones LLC | 16,956 | $27.5K | 0.00% |
| Simplex Trading, LLC | 16,454 | $26.7K | 0.00% |
| Mariner, LLC | 14,451 | $23.4K | 0.00% |
| Two Sigma Securities, LLC | 13,102 | $21.2K | 0.00% |
| Trust Co of Toledo NA | 9,000 | $14.6K | 0.00% |
| Essential Partners LLC | 2,567 | $4.16K | 0.00% |
| Federated Hermes, Inc. | 2,253 | $3.65K | 0.00% |
| Optiver Holding B.V. | 1,657 | $2.68K | 0.00% |
| EverSource Wealth Advisors, LLC | 355 | $576 | 0.00% |
| Nisa Investment Advisors, LLC | 125 | $203 | 0.00% |
| Root Financial Partners, LLC | 95 | $154 | 0.00% |
| Allworth Financial LP | 20 | $33 | 0.00% |
| Sunbelt Securities, Inc. | 17 | $28 | 0.00% |
| Rothschild Investment LLC | 11 | $18 | 0.00% |
| IFP Advisors, Inc | 5 | $8 | 0.00% |
Sold out (14)
Institutions that held Cardiff Oncology, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Two Sigma Advisers, LP | 360,500 | $1.01M |
| Candriam Luxembourg S.C.A. | 344,437 | $967.9K |
| HB Wealth Management, LLC | 71,491 | $200.9K |
| HRT Financial LP | 29,408 | $82.0K |
| Skopos Labs, Inc. | 12,649 | $37.3K |
| Belpointe Asset Management LLC | 11,778 | $33.1K |
| ProShare Advisors LLC | 11,328 | $31.8K |
| SageView Advisory Group, LLC | 6,490 | $18.2K |
| MetLife Investment Management | 6,230 | $17.5K |
| Amalgamated Bank | 1,948 | $5.00K |
| NBC Securities, Inc. | 1,000 | $2.81K |
| Cornerstone Planning Group LLC | 5 | $8 |
| Front Row Advisors LLC | 1 | $3 |
| Avion Wealth | 225 | $0 |
Not filed for Q1 2026 yet (2)
Institutions that held Cardiff Oncology, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 3,722,085 | $10.5M |
| Motiv8 Investments LLC | 200 | $1.00K |